Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
More product approvals are showing up, and demand keeps increasing for options that feel more patient friendly, and that combination keeps pushing the growth of oral GLP-1 treatments across countries
Similar content being viewed by others Introduction Amid the continuously increasing global incidence of diabetes, glucagon-like peptide-1 receptor agonists (GLP-1RAs) have emerged as a cornerstone in type 2 diabetes treatment, demonstrating remarkable efficacy in glycemic control and cardiovascular risk reduction [1, 2]
Bissonnette S, Lamantia V, Ouimet B, et al
Molecules 25 , 5591 (2020)
Ekaluo U, Ikpeme E, Ibiang Y, Amaechina O
Steenbergen, L., Sellaro, R., Hommel, B., & Colzato, L
US$ 22.42
US$ 22.95
US$ 23.01
